Search Results - "PENACK, Olaf"
-
1
Hemophagocytic lymphohistiocytosis in adults: collaborative analysis of 137 cases of a nationwide German registry
Published in Journal of cancer research and clinical oncology (01-04-2020)“…Purpose Hemophagocytic lymphohistiocytosis (HLH) is a severe hyperinflammatory syndrome emerging from a deregulated immune response due to various triggers. In…”
Get full text
Journal Article -
2
Central venous catheter–related infections in hematology and oncology: 2020 updated guidelines on diagnosis, management, and prevention by the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)
Published in Annals of hematology (01-01-2021)“…Cancer patients frequently require central venous catheters for therapy and parenteral nutrition and are at high risk of central venous catheter–related…”
Get full text
Journal Article -
3
Acute Graft-versus-Host-Disease Other Than Typical Targets: Between Myths and Facts
Published in Transplantation and cellular therapy (01-02-2021)“…•Skin, liver, and gut are not the only organs involved in acute graft-versus-host disease (aGVHD).•Kidney, bone marrow, central nervous system, and lung may be…”
Get full text
Journal Article -
4
EASIX and mortality after allogeneic stem cell transplantation
Published in Bone marrow transplantation (Basingstoke) (01-03-2020)“…Allogeneic stem cell transplantation (alloSCT) is an effective immunotherapy in patients with hematological malignancies. Endothelial dysfunction was linked to…”
Get full text
Journal Article -
5
Diagnosis and Management of Secondary HLH/MAS Following HSCT and CAR-T Cell Therapy in Adults; A Review of the Literature and a Survey of Practice Within EBMT Centres on Behalf of the Autoimmune Diseases Working Party (ADWP) and Transplant Complications Working Party (TCWP)
Published in Frontiers in immunology (31-03-2020)“…Secondary haemophagocytic lymphohistiocytosis (sHLH) or Macrophage Activation Syndrome (MAS) is a life-threatening hyperinflammatory syndrome that can occur in…”
Get full text
Journal Article -
6
Primary CD33-targeting CAR-NK cells for the treatment of acute myeloid leukemia
Published in Blood cancer journal (New York) (13-04-2022)“…Acute myeloid leukemia (AML) is a malignant disorder derived from neoplastic myeloid progenitor cells characterized by abnormal proliferation and…”
Get full text
Journal Article -
7
Editorial: Emerging talents in alloimmunity and transplantation: 2022
Published in Frontiers in immunology (2024)Get full text
Journal Article -
8
Infectious diseases in allogeneic haematopoietic stem cell transplantation: prevention and prophylaxis strategy guidelines 2016
Published in Annals of hematology (01-09-2016)“…Infectious complications after allogeneic haematopoietic stem cell transplantation (allo-HCT) remain a clinical challenge. This is a guideline provided by the…”
Get full text
Journal Article -
9
Predicting sinusoidal obstruction syndrome after allogeneic stem cell transplantation with the EASIX biomarker panel
Published in Haematologica (Roma) (01-02-2021)“…No biomarker panel is established for prediction of sinusoidal obstruction syndrome/veno-occlusive disease (SOS/VOD), a major complication of allogeneic stem…”
Get full text
Journal Article -
10
Management of complications of chimeric antigen receptor T-cell therapy: a report by the European Society of Blood and Marrow Transplantation
Published in Haematologica (Roma) (30-05-2024)“…CAR-T cells are in standard clinical use to treat relapsed or refractory hematologic malignancies, such as non-Hodgkin's lymphoma, multiple myeloma and acute…”
Get full text
Journal Article -
11
How much has allogeneic stem cell transplant–related mortality improved since the 1980s? A retrospective analysis from the EBMT
Published in Blood advances (22-12-2020)“…We performed a study to find out how advances in modern medicine have improved the mortality risk of allogeneic stem cell transplantation. We analyzed major…”
Get full text
Journal Article -
12
Editorial: Endothelial Dysfunction During Inflammation and Alloimmunity
Published in Frontiers in immunology (07-12-2018)Get full text
Journal Article -
13
Primary prophylaxis of bacterial infections and Pneumocystis jirovecii pneumonia in patients with hematologic malignancies and solid tumors: 2020 updated guidelines of the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology (AGIHO/DGHO)
Published in Annals of hematology (01-06-2021)“…Hematologic and oncologic patients with chemo- or immunotherapy-related immunosuppression are at substantial risk for bacterial infections and Pneumocystis…”
Get full text
Journal Article -
14
Association of pre-existing comorbidities with outcome of allogeneic hematopoietic cell transplantation. A retrospective analysis from the EBMT
Published in Bone marrow transplantation (Basingstoke) (01-02-2022)“…Risk assessment of allogeneic hematopoietic cell transplantation (allo-HCT) is hindered by the lack of current data on comorbidities and outcome. The EBMT…”
Get full text
Journal Article -
15
The CAR-HEMATOTOX risk-stratifies patients for severe infections and disease progression after CD19 CAR-T in R/R LBCL
Published in Journal for immunotherapy of cancer (01-05-2022)“…BackgroundCD19-directed chimeric antigen receptor T-cell therapy (CAR-T) represents a promising treatment modality for an increasing number of B-cell…”
Get full text
Journal Article -
16
Prophylaxis, diagnosis and therapy of infections in patients undergoing high-dose chemotherapy and autologous haematopoietic stem cell transplantation. 2020 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)
Published in Annals of hematology (01-02-2021)“…To ensure the safety of high-dose chemotherapy and autologous stem cell transplantation (HDC/ASCT), evidence-based recommendations on infectious complications…”
Get full text
Journal Article -
17
The induction strategies administered in the treatment of multiple myeloma exhibit a deleterious effect on the endothelium
Published in Bone marrow transplantation (Basingstoke) (01-12-2020)“…Multiple myeloma induction treatment includes proteasome inhibitors (PI) and immunomodulatory agents at present. The incidence of engraftment syndrome, a…”
Get full text
Journal Article -
18
Improved outcome of patients with graft-versus-host disease after allogeneic hematopoietic cell transplantation for hematologic malignancies over time: an EBMT mega-file study
Published in Haematologica (Roma) (01-05-2022)“…Acute graft-versus-host disease (aGvHD) remains a major threat to successful outcome following allogeneic hematopoietic cell transplantation though advances in…”
Get full text
Journal Article -
19
EASIX and Severe Endothelial Complications After CD19-Directed CAR-T Cell Therapy-A Cohort Study
Published in Frontiers in immunology (08-04-2022)“…Endothelial dysfunction is associated with two main complications of chimeric antigen receptor T (CAR-T) cell therapy, cytokine release syndrome (CRS) and…”
Get full text
Journal Article -
20
Graft-versus-host disease: regulation by microbe-associated molecules and innate immune receptors
Published in Blood (11-03-2010)“…Acute graft-versus-host disease (GVHD) remains the major obstacle to a more favorable therapeutic outcome of allogeneic hematopoietic stem cell transplantation…”
Get full text
Journal Article